You can access the annual and quarterly cash flow statements of Picard Medical Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---6.51M
---2.54M
---2.24M
Net income from continuing operations
---10.43M
---6.72M
---5.56M
Operating gains losses
--41.00K
--126.00K
--129.00K
Other non-cash items
--2.42M
--2.25M
--585.00K
Change in working capital
---3.29M
--848.00K
--736.00K
-Change in receivables
--408.00K
---1.29M
--506.00K
-Change in inventory
--266.00K
--901.00K
---246.00K
-Change in prepaid expenses
---235.00K
--102.00K
--28.00K
Cash from non-recurring investing activities
Cash from operating activities
---6.51M
---2.54M
---2.24M
Investing cash flow
Cash from non-current investing activities
Net cash flow from investing activities
----
--0.00
--0.00
Financing cash flow
Cash flow from continuous financing activities
--8.95M
--2.28M
--2.83M
Net cash flow from debt Issuance/repayment
---7.01M
--1.29M
--2.33M
Net cash flow from common stock issuance/repurchase
--15.96M
--985.00K
--500.00K
Net cash flow from other financing activities
--0.00
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
--8.95M
--2.28M
--2.83M
Net cash flow
Beginning cash balance
--410.00K
--688.00K
--96.00K
Current period cash flow changes
--2.40M
---278.00K
--592.00K
Effect of exchange rate changes
---32.00K
---15.00K
---1.00K
Ending cash balance
--2.81M
--410.00K
--688.00K
Currency unit
USD
USD
USD
Audit opinions
--
--
--
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.